Market Overview

Jim Cramer Weighs In On Valeant, Corning And Synergy Pharmaceuticals

Share:
Related VRX
10 Most Volatile Stocks Investors Should Know For Q3 Earnings
Benzinga's Option Alert Recap From October 13
The Vetr community has upgraded $VRX to 3.5-Stars. (Vetr)
Related GLW
Jim Cramer Shares His Thoughts On Corning, Procter & Gamble And More
5 Biggest Price Target Changes For Tuesday

Jim Cramer spoke on CNBC's Mad Money about Valeant Pharmaceuticals Intl Inc (NYSE: VRX). He thinks the company should do an equity offering to reduce its huge debt. There is still a large short position in the stock and some investors decided to cover it, because the downside is now quantified. He doesn't see Valeant as a good long position.

Cramer thinks Corning Incorporated (NYSE: GLW) is having a good run and the stock is a buy.

Cramer can't recommend Synergy Pharmaceuticals Inc (NASDAQ: SGYP) for anything other than a speculation. It's still in an early stage and it didn't report a good quarter.

Posted-In: Mad MoneyCNBC Jim Cramer Media

 

Related Articles (GLW + SGYP)

View Comments and Join the Discussion!
Loading...

Partner Center

Loading...